Biofrontera AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biofrontera AG with three other
companies in this sector in Germany:
sales of 6.81 million Euro [US$7.35 million]
of which 63%
(3.27 million Euro [US$3.53 million]
of which 70%
was Drug Discovery & Development), and
(2.28 million Euro [US$2.47 million]
Biofrontera AG reported sales of 4.14 million Euro (US$4.47 million)
December of 2015.
increase of 33.7%
versus 2014, when the company's sales were 3.10 million Euro.